PositiveID Corp., developer of medical technologies for diabetes management, today announced that through its certification from AT&T, it now has FDA-cleared iglucose™ mobile health system access on the AT&T network.
Designed to simplify diabetes management, iglucose is the only pocket sized, FDA-cleared, mobile health device specifically developed to connect to industry leading glucometers to transmit blood glucose readings anytime, anywhere.
The device’s functionality allows individuals with diabetes to share important glucose readings with family members, caregivers, or healthcare professionals via text, e-mail, fax, or through the iglucose diabetes management portal.
To obtain certification, laboratory testing for the iglucose device was conducted in AT&T’s wireless device testing laboratory where each device went through a series of rigorous tests to ensure operational reliability and function across the entire AT&T wireless network.
“AT&T certification, which is not easily achieved, is an important confirmation of the performance and dependability of iglucose,” PositiveID chairman and CEO William J. Caragol stated in the press release. “As we continue to prepare to roll-out this mobile health system early this year through pilot programs with insurers and home-healthcare providers, AT&T certification provides us significant validation upon which our customers and partners can rely.”
For more information visit www.PositiveIDCorp.com
Let us hear your thoughts below: